These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9569998)

  • 1. Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers.
    Wong SL; Drajesk J; Chang MS; Witt G; Awni WM
    Biopharm Drug Dispos; 1998 Apr; 19(3):159-62. PubMed ID: 9569998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ABT-761, a novel 5-lipoxygenase inhibitor, on the pharmacokinetics of a single dose of ethinyl estradiol and levonorgestrel in healthy female volunteers.
    Wong SL; O'Dea RF; Dube LM; Awni WM
    J Clin Pharmacol; 1998 Jul; 38(7):642-8. PubMed ID: 9702850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.
    Wong SL; Drajesk J; Chang M; Lanni C; Witt G; Hansen R; Awni WM
    Clin Pharmacol Ther; 1998 Mar; 63(3):324-31. PubMed ID: 9542476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma.
    Wong SL; Kearns GL; Kemp JP; Drajesk J; Chang M; Locke CS; Dube LM; Awni WM
    Eur J Clin Pharmacol; 1998; 54(9-10):715-9. PubMed ID: 9923573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABT-761 (Abbott).
    Reid JJ
    Curr Opin Investig Drugs; 2001 Jan; 2(1):68-71. PubMed ID: 11527015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interactions between zileuton and prednisone.
    Awni WM; Cavanaugh JH; Tzeng TB; Witt G; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():105-11. PubMed ID: 8620666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetic and pharmacodynamic interactions between the 5-lipoxygenase inhibitor zileuton and the cyclo-oxygenase inhibitor naproxen in human volunteers.
    Awni WM; Braeckman RA; Cavanaugh JH; Locke CS; Linnen PJ; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():112-24. PubMed ID: 8620667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, safety, and ability to diminish leukotriene synthesis by zileuton, an inhibitor of 5-lipoxygenase.
    Rubin P; Dubé L; Braeckman R; Swanson L; Hansen R; Albert D; Carter G
    Agents Actions Suppl; 1991; 35():103-16. PubMed ID: 1781415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of single oral doses of zileuton 200 to 800mg, its enantiomers, and its metabolites, in normal healthy volunteers.
    Wong SL; Awni WM; Cavanaugh JH; el-Shourbagy T; Locke CS; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():9-21. PubMed ID: 8620676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
    Van Schoor J; Joos GF; Kips JC; Drajesk JF; Carpentier PJ; Pauwels RA
    Am J Respir Crit Care Med; 1997 Mar; 155(3):875-80. PubMed ID: 9117020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of cytochrome P450 1A2 interaction effect of ABT-761 on the pharmacokinetics of theophylline.
    Wong SL; Cavanaugh JH; Qian J; Hansen R; Awni WM
    Am J Ther; 1998 Sep; 5(5):303-6. PubMed ID: 10099073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of zileuton on theophylline pharmacokinetics.
    Granneman GR; Braeckman RA; Locke CS; Cavanaugh JH; Dubé LM; Awni WM
    Clin Pharmacokinet; 1995; 29 Suppl 2():77-83. PubMed ID: 8620674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a 5-lipoxygenase inhibitor, ABT-761, on exercise-induced bronchoconstriction and urinary LTE4 in asthmatic patients.
    Lehnigk B; Rabe KF; Dent G; Herst RS; Carpentier PJ; Magnussen H
    Eur Respir J; 1998 Mar; 11(3):617-23. PubMed ID: 9596112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of food on the pharmacokinetics of zileuton.
    Awni WM; Cavanaugh JH; Witt G; Granneman GR; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():62-6. PubMed ID: 8620672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.
    Awni WM; Braeckman RA; Granneman GR; Witt G; Dubé LM
    Clin Pharmacokinet; 1995; 29 Suppl 2():22-33. PubMed ID: 8620668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the diurnal variation in the pharmacokinetics of zileuton in healthy volunteers.
    Awni WM; Locke C; Dube LM; Cavanaugh JH
    J Clin Pharmacol; 1997 May; 37(5):388-94. PubMed ID: 9156371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single- and multiple-dose pharmacokinetics, safety, and tolerability of the selective alpha7 neuronal nicotinic receptor agonist, ABT-107, in healthy human volunteers.
    Othman AA; Lenz RA; Zhang J; Li J; Awni WM; Dutta S
    J Clin Pharmacol; 2011 Apr; 51(4):512-26. PubMed ID: 20495134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis.
    Mohamed MF; Camp HS; Jiang P; Padley RJ; Asatryan A; Othman AA
    Clin Pharmacokinet; 2016 Dec; 55(12):1547-1558. PubMed ID: 27272171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the human liver cytochrome P450 enzymes involved in the in vitro metabolism of a novel 5-lipoxygenase inhibitor.
    Machinist JM; Mayer MD; Roberts EM; Surber BW; Rodrigues AD
    Drug Metab Dispos; 1998 Oct; 26(10):970-6. PubMed ID: 9763401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.